PMID- 24142413 OWN - NLM STAT- MEDLINE DCOM- 20140217 LR - 20211021 IS - 1522-1539 (Electronic) IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 305 IP - 12 DP - 2013 Dec TI - Reduced BDNF attenuates inflammation and angiogenesis to improve survival and cardiac function following myocardial infarction in mice. PG - H1830-42 LID - 10.1152/ajpheart.00224.2013 [doi] AB - Brain-derived neurotrophic factor (BDNF) increases in failing hearts, but BDNF roles in cardiac remodeling following myocardial infarction (MI) are unclear. Male BDNF(+/+) [wild-type (WT)] and BDNF(+/-) heterozygous (HET) mice at 6-9 mo of age were subjected to MI and evaluated at days 1, 3, 5, 7, or 28 post-MI. At day 28 post-MI, 76% of HET versus 40% of WT survived, whereas fractional shortening improved and neovascularization levels were reduced in the HET (all, P < 0.05). At day 1, post-MI, matrix metalloproteinase-9, and myeloperoxidase (MPO) increased in WT, but not in HET. Concomitantly, monocyte chemotactic protein-1 and -5 levels increased and vascular endothelial growth factor (VEGF)-A decreased in HET. Neutrophil infiltration peaked at days 1-3 in WT mice, and this increase was blunted in HET. To determine if MPO administration could rescue the HET phenotype, MPO was injected at 3 h post-MI. MPO restored VEGF-A levels without altering matrix metalloproteinase-9 or neutrophil content. In conclusion, reduced BDNF levels modulated the early inflammatory and neovascularization responses, leading to improved survival and reduced cardiac remodeling at day 28 post-MI. Thus reduced BDNF attenuates early inflammation following MI by modulating MPO and angiogenic response through VEGF-A. FAU - Halade, Ganesh V AU - Halade GV AD - San Antonio Cardiovascular Proteomics Center, San Antonio, Texas; FAU - Ma, Yonggang AU - Ma Y FAU - Ramirez, Trevi A AU - Ramirez TA FAU - Zhang, Jianhua AU - Zhang J FAU - Dai, Qiuxia AU - Dai Q FAU - Hensler, Julie G AU - Hensler JG FAU - Lopez, Elizabeth F AU - Lopez EF FAU - Ghasemi, Omid AU - Ghasemi O FAU - Jin, Yu-Fang AU - Jin YF FAU - Lindsey, Merry L AU - Lindsey ML LA - eng GR - R01-HL-075360/HL/NHLBI NIH HHS/United States GR - EB009496/EB/NIBIB NIH HHS/United States GR - R01 HL075360/HL/NHLBI NIH HHS/United States GR - R00 AT006704/AT/NCCIH NIH HHS/United States GR - N01-HV-00244/HV/NHLBI NIH HHS/United States GR - 1SC2 HL101430/HL/NHLBI NIH HHS/United States GR - I01 BX000505/BX/BLRD VA/United States GR - R00AT006704/AT/NCCIH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20131018 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Vascular Endothelial Growth Factor A) RN - EC 1.11.1.7 (Peroxidase) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/genetics/*metabolism MH - Heart/drug effects/*physiopathology MH - Heterozygote MH - Inflammation/genetics/*metabolism MH - Male MH - Matrix Metalloproteinase 9/metabolism MH - Mice MH - Mice, Knockout MH - Myocardial Infarction/genetics/*metabolism/physiopathology MH - Myocardium/*metabolism MH - Neovascularization, Pathologic/genetics/*metabolism MH - Neutrophils/drug effects/metabolism MH - Peroxidase/metabolism/pharmacology MH - Vascular Endothelial Growth Factor A/metabolism PMC - PMC3882541 OTO - NOTNLM OT - brain-derived neurotrophic factor OT - inflammation OT - myeloperoxidase OT - myocardial infarction OT - obesity OT - proteomic profiling EDAT- 2013/10/22 06:00 MHDA- 2014/02/18 06:00 PMCR- 2014/12/15 CRDT- 2013/10/22 06:00 PHST- 2013/10/22 06:00 [entrez] PHST- 2013/10/22 06:00 [pubmed] PHST- 2014/02/18 06:00 [medline] PHST- 2014/12/15 00:00 [pmc-release] AID - ajpheart.00224.2013 [pii] AID - H-00224-2013 [pii] AID - 10.1152/ajpheart.00224.2013 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2013 Dec;305(12):H1830-42. doi: 10.1152/ajpheart.00224.2013. Epub 2013 Oct 18.